Volume 52, Issue 1, Pages (July 2007)

Slides:



Advertisements
Similar presentations
Volume 63, Issue 3, Pages (March 2013)
Advertisements

Volume 50, Issue 1, Pages (July 2006)
Volume 51, Issue 2, Pages (February 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 58, Issue 2, Pages (August 2010)
Volume 70, Issue 1, Pages (July 2016)
Testosterone Therapy in Men With Prostate Cancer
Volume 59, Issue 3, Pages (March 2011)
Volume 61, Issue 5, Pages (May 2012)
Volume 51, Issue 1, Pages (January 2007)
Volume 69, Issue 1, Pages (January 2016)
Volume 71, Issue 6, Pages e171-e172 (June 2017)
Let the Games Begin (with EAU Approval)
Volume 68, Issue 1, Pages (July 2015)
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Volume 51, Issue 5, Pages (May 2007)
Prostate Cancer Epidemic in Sight?
Volume 63, Issue 1, Pages (January 2013)
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Volume 53, Issue 2, Pages (February 2008)
Volume 74, Issue 1, Pages (July 2018)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 59, Issue 3, Pages (March 2011)
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 54, Issue 4, Pages (October 2008)
Volume 61, Issue 5, Pages (May 2012)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma
Volume 66, Issue 5, Pages (November 2014)
Volume 68, Issue 1, Pages (July 2015)
Volume 69, Issue 4, Pages (April 2016)
Volume 70, Issue 1, Pages (July 2016)
Volume 64, Issue 3, Pages (September 2013)
Volume 67, Issue 3, Pages (March 2015)
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Prostate Cancer Epidemic in Sight?
Volume 50, Issue 3, Pages (September 2006)
Volume 61, Issue 6, Pages (June 2012)
Volume 60, Issue 6, Pages (December 2011)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 53, Issue 6, Pages (June 2008)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 47, Issue 1, Pages (January 2005)
Volume 52, Issue 1, Pages (July 2007)
Volume 53, Issue 1, Pages (January 2008)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 6, Pages (June 2009)
Volume 74, Issue 5, Pages (November 2018)
Testicular Cancer Variations in Time and Space in Europe
Overall survival in the IFCT trial comparing a single agent therapy arm (vinorelbine or gemcitabine) and the doublet carboplatin plus weekly paclitaxel.
Volume 70, Issue 1, Pages (July 2016)
European Urology is “Your” Journal
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
Volume 54, Issue 1, Pages (July 2008)
European Association of Urology Guidelines for Systemic Therapy in Metastatic Renal Cell Carcinoma: What is Recommended and Why?  Jean-Jacques Patard 
Volume 67, Issue 3, Pages (March 2015)
Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II.
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Annika Berntsen, Poul F. Geertsen, Inge Marie Svane  European Urology 
Joaquim Bellmunt  European Urology Supplements 
Volume 51, Issue 2, Pages (February 2007)
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Volume 67, Issue 4, Pages (April 2015)
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
A Phase III Randomized Trial of Gemcitabine–Oxaliplatin versus Carboplatin–Paclitaxel as First-Line Therapy in Patients with Advanced Non-small Cell Lung.
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
A Randomized Phase II Trial Assessing in Advanced Non-small Cell Lung Cancer Patients with Stable Disease after Two Courses of Cisplatin-Gemcitabine an.
Presentation transcript:

Volume 52, Issue 1, Pages 134-141 (July 2007) Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial  Luigi Dogliotti, Giacomo Cartenì, Salvatore Siena, Oscar Bertetto, Andrea Martoni, Aldo Bono, Dino Amadori, Haluk Onat, Luca Marini  European Urology  Volume 52, Issue 1, Pages 134-141 (July 2007) DOI: 10.1016/j.eururo.2006.12.029 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Time to progressive disease for the gemcitabine–carboplatin (GC) arm and the gemcitabine–cisplatin (GP) arm. European Urology 2007 52, 134-141DOI: (10.1016/j.eururo.2006.12.029) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 2 Overall survival for the gemcitabine–carboplatin (GC) arm and the gemcitabine–cisplatin (GP) arm. European Urology 2007 52, 134-141DOI: (10.1016/j.eururo.2006.12.029) Copyright © 2007 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.